Kestra Medical Technologies (KMTS) Operating Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Operating Expenses data on file, last reported at $47.7 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $47.7 million, up 75.6% year-over-year; the trailing twelve-month figure through Jan 2026 was $184.4 million (up 91.13% YoY), and the FY2025 annual result was $130.6 million, up 52.87% from the prior year.
• Operating Expenses rose to $47.7 million in Q1 2026 per KMTS's latest filing, from $43.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $55.8 million in Q2 2025 and troughed at $20.8 million in Q1 2024.
• A 3-year average of $33.5 million and a median of $27.1 million in 2025 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 156.81% in 2025 and fell as far as 30.36% in 2025.
• A 3-year view of Operating Expenses shows it stood at $25.0 million in 2024, then surged by 72.97% to $43.2 million in 2025, then rose by 10.4% to $47.7 million in 2026.
• Business Quant data shows KMTS's Operating Expenses at $47.7 million in Q1 2026, $43.2 million in Q4 2025, and $37.7 million in Q3 2025.